Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils
Open Access
- 4 November 2009
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 87 (2) , 291-300
- https://doi.org/10.1189/jlb.0509336
Abstract
The critical signaling kinase of IgE-mediated reactions, syk, can be down-regulated in maturing basophils by chronic ag-gregation without altering their expression of FcRI, granule staining, and histamine content. In human basophils from different subjects, maximum IgE-mediated histamine release and the level of syk protein expression correlate well. It is not clear when in the basophil’s lifetime the set-point for syk expression is reached or how expression levels are determined for a given individual. An examination of syk expression in peripheral blood eosinophils, neutrophils, monocytes, B and T cells, DCs, and NK cells showed that with the exception of T cells, basophils were unique in expressing low levels of syk. No correlations were observed between syk expression in basophils and other types of leukocytes, suggesting a unique mechanism of regulation for basophils. The expression level of syk in CD34+ progenitors was ∼11-fold higher than in peripheral blood basophils, and it remained at this level during maturation of the cells in IL-3 to a cell with characteristics of peripheral blood basophils. Down-regulation of syk expression in the culture-derived basophils was induced by culturing under conditions of chronic aggregation of FcεRI. Syk was down-regulated to peripheral blood basophil levels in 50% of the cells. Despite the chronic aggregation of FcεRI, the cells retained the same expression of FcεRI, histamine content, and morphological staining of granules as cells not experiencing chronic aggregation. These results suggest that chronic stimulation through FcεRI during basophil maturation might be a mechanism for down-regulating syk expression, while retaining other characteristics associated with mature peripheral blood basophils.Keywords
Funding Information
- National Institutes of Health (AI20253, AI070345)
This publication has 40 references indexed in Scilit:
- Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti‐IgE treatmentAllergy, 2008
- Basophil Phenotypes in Chronic Idiopathic Urticaria in Relation to Disease Activity and AutoantibodiesJournal of Investigative Dermatology, 2008
- Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil modelsJournal of Leukocyte Biology, 2008
- Endocytosis, recycling, and degradation of unoccupied FcεRI in human basophilsJournal of Leukocyte Biology, 2007
- Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challengeJournal of Allergy and Clinical Immunology, 2005
- Antigen-Induced Reduction in Mast Cell and Basophil Functional Responses due to Reduced Syk Protein LevelsInternational Archives of Allergy and Immunology, 2005
- Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticariaPublished by Elsevier ,2005
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆Journal of Allergy and Clinical Immunology, 2004
- Nonreleasing basophils convert to releasing basophils by culturing with IL-3Journal of Allergy and Clinical Immunology, 1996
- The concept of basophil releasibilityJournal of Allergy and Clinical Immunology, 1986